NASDAQ:CUTR - Cutera Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $70.60
  • Forecasted Upside: 35.72 %
  • Number of Analysts: 3
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
$52.02
▼ -1.26 (-2.36%)

This chart shows the closing price for CUTR by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Cutera Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CUTR and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CUTR

Analyst Price Target is $70.60
▲ +35.72% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for Cutera in the last 3 months. The average price target is $70.60, with a high forecast of $0.00 and a low forecast of $0.00. The average price target represents a 35.72% upside from the last price of $52.02.

This chart shows the closing price for CUTR for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 3 investment analysts is to buy stock in Cutera. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/25/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/23/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/24/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/22/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/20/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/18/2022
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/19/2022
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/19/2022

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/9/2022StephensBoost Price Target$68.00 ➝ $78.00High
5/5/2022Maxim GroupBoost Price Target$60.00 ➝ $80.00Medium
3/28/2022Stifel NicolausBoost Price Target$60.00 ➝ $70.00High
11/4/2021Maxim GroupUpgradeHold ➝ Buy$60.00High
8/5/2021Piper SandlerBoost Price TargetOverweight$42.00 ➝ $65.00High
7/13/2021Cantor FitzgeraldBoost Price TargetOverweight$55.00 ➝ $60.00Low
6/2/2021Cantor FitzgeraldInitiated CoverageOverweight$55.00High
3/5/2021Piper SandlerBoost Price TargetOverweight$38.00 ➝ $42.00High
2/18/2021Piper SandlerBoost Price TargetOverweight$28.00 ➝ $38.00High
11/5/2020Piper SandlerBoost Price TargetOverweight$22.00 ➝ $28.00High
9/30/2020Piper SandlerBoost Price TargetOverweight$18.00 ➝ $22.00High
9/14/2020StephensBoost Price TargetOverweight$18.00 ➝ $24.00High
5/8/2020Maxim GroupReiterated RatingHoldLow
5/5/2020Stifel NicolausUpgradeHold ➝ Buy$32.00 ➝ $26.00High
4/22/2020Piper SandlerInitiated CoverageOverweight$18.00Low
3/23/2020StephensLower Price TargetOverweight$45.00 ➝ $15.00High
2/28/2020Maxim GroupReiterated RatingHoldMedium
11/8/2019StephensBoost Price TargetOverweight$35.00 ➝ $45.00High
8/22/2019SidotiDowngradeBuy ➝ NeutralHigh
8/9/2019Maxim GroupReiterated RatingHoldLow
2/21/2019StephensLower Price TargetOverweight$40.00 ➝ $25.00High
2/11/2019Maxim GroupReiterated RatingHoldMedium
1/8/2019Maxim GroupReiterated RatingHoldHigh
10/5/2018SidotiSet Price TargetBuy$50.00High
10/5/2018StephensLower Price TargetUnderperform ➝ Sell$40.00 ➝ $24.94High
10/5/2018Stifel NicolausLower Price TargetHold ➝ Hold$45.00 ➝ $29.00High
8/8/2018Stifel NicolausLower Price TargetHold ➝ Hold$55.00 ➝ $45.00High
4/16/2018Stifel NicolausInitiated CoverageHold ➝ Hold$55.00High
3/13/2018StephensInitiated CoverageOverweight$60.00High
2/16/2018GabelliReiterated RatingBuyLow
11/8/2017Maxim GroupReiterated RatingHoldN/A
9/14/2017Maxim GroupDowngradeBuy ➝ HoldLow
9/12/2017Roth CapitalBoost Price TargetBuy$41.00 ➝ $47.00High
8/9/2017GabelliReiterated RatingBuyHigh
8/8/2017Roth CapitalBoost Price TargetBuy$32.00 ➝ $39.00High
7/13/2017Maxim GroupReiterated RatingBuy ➝ Buy$27.00 ➝ $33.00Low
7/7/2017SidotiReiterated RatingBuy$30.00 ➝ $32.00Medium
6/26/2017Roth CapitalInitiated CoverageBuy$32.00High
6/3/2017SidotiReiterated RatingBuy$27.00 ➝ $30.00Low
(Data available from 5/19/2017 forward)

News Sentiment Rating

0.30 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 5 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
10/21/2021
  • 3 very positive mentions
  • 15 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
11/20/2021
  • 4 very positive mentions
  • 10 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
12/20/2021
  • 0 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/19/2022
  • 1 very positive mentions
  • 12 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
2/18/2022
  • 2 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/20/2022
  • 2 very positive mentions
  • 6 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
4/19/2022
  • 5 very positive mentions
  • 14 positive mentions
  • 7 negative mentions
  • 0 very negative mentions
5/19/2022

Current Sentiment

  • 5 very positive mentions
  • 14 positive mentions
  • 7 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.
Cutera logo
Cutera, Inc., a medical device company, researches, develops, manufactures, markets, and services laser and energy-based aesthetics systems for practitioners worldwide. The company offers Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for deep dermal remodeling; truSculpt flex, a bio-electrical muscle stimulation device to treat patients at all fitness levels; excel V+, a vascular and benign pigmented lesion treatment platform; truSculpt iD, for the non-surgical body sculpting market; and Secret RF, a fractional RF microneedling system for tissue coagulation and hemostasis. It also provides enlighten platform, a laser system that is used for tattoo removal, as well as to treat benign pigmented lesions and acne scars; excel HR platform, a hair removal solution for various skin types; and xeo platform, a multi-application platform on which a customer purchases hand piece applications for the removal of unwanted hair, treatment of vascular lesions, and skin revitalization by treating discoloration, fine lines, and laxity. In addition, the company distributes skincare products; and offers post-warranty services through extended service contracts or direct billing. Further, it provides pulsed light hand pieces for the treatment of discoloration, hair removal, and vascular treatments; and Pearl and Pearl Fractional hand pieces, as well as sells hand piece refills, cycle refills, consumable tips, and marketing brochures through the company's website. The company markets and sells its products through direct sales force to plastic surgeons, dermatologists, gynecologists, family practitioners, primary care physicians, and other qualified practitioners, as well as for physicians performing aesthetic treatments in non-medical offices. Cutera, Inc. was incorporated in 1988 and is headquartered in Brisbane, California.
Read More

Today's Range

Now: $52.02
Low: $50.77
High: $53.09

50 Day Range

MA: $58.02
Low: $41.50
High: $72.31

52 Week Range

Now: $52.02
Low: $30.20
High: $74.38

Volume

323,343 shs

Average Volume

513,152 shs

Market Capitalization

$944.68 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.79

Frequently Asked Questions

What sell-side analysts currently cover shares of Cutera?

The following sell-side analysts have issued stock ratings on Cutera in the last twelve months: Cantor Fitzgerald, Maxim Group, Piper Sandler, Stephens, Stifel Nicolaus, StockNews.com, TheStreet, and Zacks Investment Research.
View the latest analyst ratings for CUTR.

What is the current price target for Cutera?

0 Wall Street analysts have set twelve-month price targets for Cutera in the last year. Their average twelve-month price target is $70.60, suggesting a possible upside of 35.7%.
View the latest price targets for CUTR.

What is the current consensus analyst rating for Cutera?

Cutera currently has 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe CUTR will outperform the market and that investors should add to their positions of Cutera.
View the latest ratings for CUTR.

How do I contact Cutera's investor relations team?

Cutera's physical mailing address is 3240 BAYSHORE BOULEVARD, BRISBANE CA, 94005. The medical device company's listed phone number is (415) 657-5500 and its investor relations email address is [email protected] The official website for Cutera is www.cutera.com. Learn More about contacing Cutera investor relations.